MDRuijin HospitalShanghai, Shanghai, China (People's Republic)
Disclosure information not submitted.
LB4 - Total Neoadjuvant Therapy With mFOLFOX6 Plus Bevacizumab and Short-course Radiotherapy for Ras-mutant, High-risk Locally Advanced Rectal Cancer: The TRAINER Trial
Monday, May 12, 20258:30 AM - 8:38 AM PT